The regulation of SOX2 by SHH occurs in neural and brain stem cells (40, 41), and the pharmacological inhibition of these pathways silences SOX2 expression and impairs glioma cells’ tumorigenic activity (16). This evidence concerns the gene SOX2 and central nervous system cancer.